Technical analysis of Anteris Technologies Global Corp. (AVR): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Anteris Technologies Global Corp. is a structural heart innovator dedicated to discovering, developing, and bringing to market medical devices that enhance the well-being of patients grappling with aortic stenosis. The company's premier offering is the DurAVR transcatheter heart valve system, a pioneering transcatheter aortic valve engineered to treat aortic stenosis by precisely emulating the performance of a healthy human aortic valve.
Price Performance
| 1 month | -12.11% |
| 3 months | -13.91% |
| Year-to-date | +68.74% |
| 1 year | +50.09% |
52-Week Range
| 52-week High | $11.06 |
| 52-week Low | $3.30 |
| Avg Volume (90d) | 1.1M |
Technical Indicators
| SMA 50 | $8.69 |
| SMA 200 | $7.08 |
| Beta | 0.55 |
| 30-day Volatility (annualised) | 46.7% |
| Price vs SMA 50 | -3.1% |
| Price vs SMA 200 | +19.0% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $4.49 | |
| 2025-11 | $4.10 | -8.7% |
| 2025-12 | $4.99 | +21.7% |
| 2026-01 | $5.97 | +19.6% |
| 2026-02 | $6.51 | +9.0% |
| 2026-03 | $5.55 | -14.7% |
| 2026-04 | $6.15 | +10.8% |
| 2026-05 | $8.62 | +40.2% |
| 2026-06 | $9.85 | +14.3% |
| 2026-07 | $7.84 | -20.4% |
| 2026-08 | $8.61 | +9.8% |
| 2026-09 | $8.42 | -2.2% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-15 | $0.18 | $607M |
| 2026-09-15 | | $24M |
| 2026-09-15 | | |
| 2026-09-15 | | |
| 2026-09-15 | | $42M |
| 2026-09-15 | | |
Price
| Price | $8.42 |
| Market Cap | $819M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 3.24 |
| EV / EBITDA | -5.56 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.01 |
| Current Ratio | 14.20 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -31.49 |